Clearance of host cell impurities from plasmid-containing lysates by boronate adsorption

被引:22
作者
Gomes, A. Gabriela [1 ]
Azevedo, Ana M. [1 ]
Aires-Barros, M. Raquel [1 ]
Prazeres, D. Miguel F. [1 ]
机构
[1] Univ Tecn Lisboa, IBB, Ctr Biol & Chem Engn, Inst Super Tecn, P-1049001 Lisbon, Portugal
关键词
Gene therapy; Plasmid DNA; RNA; Lipopolysaccharides; Genomic DNA; Affinity process; Phenyl boronate; Adsorption; Purification; Chromatography; GENE-THERAPY; SCALE PRODUCTION; ACID COMPLEXES; DNA; PURIFICATION; VACCINE; DIOLS;
D O I
10.1016/j.chroma.2010.02.015
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The ability of boronate adsorption to clear Escherichia coli impurities directly from plasmid-containing lysates (similar to pH 5.2) was evaluated. Results show that 3-aminophenyl boronate (PB) controlled pore glass (CPG) is able to adsorb not only those species that bear cis-diol groups (RNA, lipopolysaccharides-LPS), and are thus able to form covalent bonds with boronate, but also cis-diol-free proteins and genomic DNA (gDNA) fragments, while leaving most plasmid DNA in solution. Control runs performed with phenyl Sepharose and with PB-free CPG beads ruled out hydrophobic interactions with the phenyl ring and non-specific interactions with the glass matrix, respectively, as being responsible for RNA and gDNA adsorption. In batch mode, up to 97.6 +/- 3.1% of RNA, 94.6 +/- 0.8% of proteins and 96.7 +/- 11.7% of gDNA were cleared after 30 min, with a plasmid yield of 64%. In fixed-bed mode, most of the plasmid was recovered in the flowthrough (96.2 +/- 4.0%), even though the RNA (65.5 +/- 2.8%), protein (84.4 +/- 1.3%) and gDNA clearance (44.7 +/- 14.1%) were not as effective. In both cases, the LPS content was removed to a residual value of less than 0.005 EU/ml. The method is fast and straightforward, circumvents the need for pre-treatment of the feed and may contribute to shorten plasmid purification processes, as the treated streams can proceed directly to the final polishing steps. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:2262 / 2266
页数:5
相关论文
共 14 条
[1]   Binary and ternary phenylboronic acid complexes with saccharides and Lewis bases [J].
Bosch, LI ;
Fyles, TM ;
James, TD .
TETRAHEDRON, 2004, 60 (49) :11175-11190
[2]   Phenyl boronic acid complexes of diols and hydroxyacids [J].
Bromba, Caleb ;
Carrie, Philippa ;
Chui, Jonathan K. W. ;
Fyles, Thomas M. .
SUPRAMOLECULAR CHEMISTRY, 2009, 21 (1-2) :81-88
[3]  
Cai Y, 2009, EXPERT REV VACCINES, V8, P1277, DOI [10.1586/erv.09.84, 10.1586/ERV.09.84]
[4]  
Carnes Aaron E, 2007, Recent Pat Biotechnol, V1, P151, DOI 10.2174/187220807780809436
[5]   Assessment of purity and quantification of plasmid DNA in process solutions using high-performance hydrophobic interaction chromatography [J].
Diogo, MM ;
Queiroz, JA ;
Prazeres, DMF .
JOURNAL OF CHROMATOGRAPHY A, 2003, 998 (1-2) :109-117
[6]   Purification of plasmid DNA with aqueous two phase systems of PEG 600 and sodium citrate/ammonium sulfate [J].
Gomes, Gabriela A. ;
Azevedo, Ana M. ;
Aires-Barros, M. Raquel ;
Prazeres, D. Miguel F. .
SEPARATION AND PURIFICATION TECHNOLOGY, 2009, 65 (01) :22-30
[7]   Perspectives on plasmid-based gene therapy: challenges for the product and the process [J].
Kelly, WJ .
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2003, 37 :219-223
[8]   Boronic Acids as Ligands for Affinity Chromatography [J].
Liu Xiao-Chuan .
CHINESE JOURNAL OF CHROMATOGRAPHY, 2006, 24 (01) :73-80
[9]   Comparison of real-time polymerase chain reaction and hybridization assays for the detection of Escherichia coli genomic DNA in process samples and pharmaceutical-grade plasmid DNA products [J].
Martins, SAM ;
Prazeres, DMF ;
Cabral, JMS ;
Monteiro, GA .
ANALYTICAL BIOCHEMISTRY, 2003, 322 (01) :127-129
[10]   Nonviral vectors in the new millennium: Delivery barriers in gene transfer [J].
Nishikawa, M ;
Huang, L .
HUMAN GENE THERAPY, 2001, 12 (08) :861-870